» Articles » PMID: 22210668

Ocular Manifestations As Key Features for Diagnosing Mucopolysaccharidoses

Overview
Specialty Rheumatology
Date 2012 Jan 3
PMID 22210668
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Diagnosis of mucopolysaccharidosis (MPS) requires awareness of the multisystem disease manifestations and their diverse presentation in terms of time of onset and severity. Many patients with MPS remain undiagnosed for years and progressively develop irreversible pathologies, which ultimately lead to premature death. To foster timely treatment and ensure a better outcome, it is of utmost importance to recognize and evaluate the typical ocular features that present fairly early in the course of the disease in many children with MPS. These include corneal clouding, ocular hypertension/glaucoma, retinal degeneration, optic disc swelling and optic nerve atrophy. Other associations include pseudo-exophthalmos, amblyopia, strabismus and large refractive errors requiring spectacle correction. While some ocular manifestations require specialized equipment for detecting abnormalities, light sensitivity, pseudo-exophthalmos and strabismus are often apparent on a routine physical examination. In addition, patients may be symptomatic from vision impairment, photosensitivity, night blindness and visual field constriction. Combined with the skeletal/joint complications and other manifestations, these ocular features are key in the differential diagnosis of children with joint abnormalities. Rheumatologists should have a high index of suspicion for MPS to facilitate early diagnosis. Referral to a geneticist, a metabolic specialist or physician who specializes in MPS can confirm the diagnosis and provide disease management. Consultation with an ophthalmologist who has expertise in MPS is also needed for thorough examination of the eyes and regular follow-up care.

Citing Articles

Hurler Syndrome (Mucopolysaccharidosis Type 1): A Case Report.

Khalid N, Abdullah M, Awais A, Hassan M, Muhammad A Cureus. 2023; 15(4):e37785.

PMID: 37213966 PMC: 10195038. DOI: 10.7759/cureus.37785.


Ocular Manifestations of Hurler-Scheie Syndrome: Recurrence of Host Disease in the Corneal Transplant.

Kolkedi Z, Csutak A, Szalai E Mol Syndromol. 2023; 14(1):44-50.

PMID: 36777710 PMC: 9911992. DOI: 10.1159/000525453.


Dilated Optic Nerve Sheath in Mucopolysaccharidosis I: Common and Not Necessarily High Intracranial Pressure.

Huang S, Lund T, Orchard P, Gupta A, Nascene D AJNR Am J Neuroradiol. 2022; 44(1):91-94.

PMID: 36581456 PMC: 9835902. DOI: 10.3174/ajnr.A7755.


Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders.

Balikov D, Jacobson A, Prasov L Genes (Basel). 2021; 12(9).

PMID: 34573386 PMC: 8471311. DOI: 10.3390/genes12091403.


Management of Corneal Clouding in Patients with Mucopolysaccharidosis.

McGrath O, Au L, Ashworth J J Clin Med. 2021; 10(15).

PMID: 34362047 PMC: 8348690. DOI: 10.3390/jcm10153263.